Amylin Pharmaceuticals
Bruce Powell has extensive experience in regulatory affairs, currently serving as a Regulatory Affairs Manager at Amylin Pharmaceuticals since April 2006. Prior to this role, Bruce held the position of Manager of Regulatory Affairs at Biogen Idec from April 1994 to September 2005. Earlier in Bruce's career, experience included working as a Production Chemist at Hybritech from 1990 to 1994. Bruce Powell's educational background includes studies at UC San Diego.
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.Develops a line of diagnostic and therapeutic products for diabetics.Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside thebox". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.